GBP4 and melanoma: Among the seven component genes of TxflSig1, we recently made several interesting observations of GBP4, including its induction by a gain-of-function PCSK9 mutant in melanoma; its expression being positively associated with T cell dysfunction [52], and its biomarker value in predicting response to ICB therapy (manuscript in preparation).